Safety of Simvastatin and Goal Attainment for Low-Density Lipoprotein Cholesterol in Sultan Qaboos University Hospital

Objectives: Despite the scientific evidence of reducing cardiac events with HMG Co-A reductase inhibitors (statins) therapy in both primary and secondary preventions, these therapies continue to be underutilized in patients receiving convictional care. Simvastatin, a HMG Co-A inhibitor agent, is the...

Full description

Bibliographic Details
Main Authors: Khalid Al-Siyabi, Hatem Farhan, Khalid Al-Rasadi, Amaal Al-Salhi, Ali T. Al-Hinai, Ibrahim Al-Zakwani
Format: Article
Language:English
Published: Oman Medical Specialty Board 2010-10-01
Series:Oman Medical Journal
Subjects:
Online Access:http://www.omjournal.org/fultext_PDF.aspx?DetailsID=17&type=fultext